VIVOLTA expands facility to scale electrospun medical implants manufacturing
Eindhoven, Netherlands, November 3, 2025 — Medical-device CDMO VIVOLTA has signed a long-term agreement for a dedicated production facility...
Advertisement
Government contract pursuit advances Halberd TBI nasal-spray program
JACKSON CENTER, Pa., November 3, 2025 — Halberd Corporation, in collaboration with Mississippi State University (MSU), announced continued efforts...
AAVantgarde Secures $141 Million Series B to Advance Gene Therapies for Retinal Diseases
LONDON/MILAN, Nov. 3, 2025 — AAVantgarde Bio has raised $141 million in a Series B financing round, co-led by...
BioNTech Advances Oncology Pipeline and Strengthens 2025 Financial Outlook
MAINZ, Germany, November 3, 2025 — BioNTech SE (Nasdaq: BNTX) reported its third quarter 2025 financial results, highlighting significant...
Headline (SEO-Optimized, ≤60 characters):Actimed Secures Key Japan Patent for Muscle-Wasting Drug
London, UK – November 3, 2025 Actimed Therapeutics Ltd, a UK-based clinical-stage specialty pharmaceutical company, has announced the grant...
Aptose to Present Promising Tuspetinib AML Data at 2025 ASH Meeting
SAN DIEGO and TORONTO, November 3, 2025 — Aptose Biosciences Inc. (TSX: APS), a clinical-stage precision oncology company, announced...
GC Biopharma’s Recombinant Anthrax Vaccine Shows Strong Phase 2 Safety and Efficacy Results
Yongin, South Korea — November 3, 2025 GC Biopharma has announced promising Phase 2 clinical trial results for its...
MSD Animal Health Data Confirms Efficacy of Intranasal Bovine Coronavirus Vaccine
BOXMEER, The Netherlands — October 23, 2025 — MSD Animal Health, a global leader in veterinary biopharmaceutical innovation, announced...
CS Diagnostics Strengthens Financial Structure Through Share Conversion
NEW YORK, November 3, 2025 — CS Interpharm and CS Diagnostics Pharma (CSDX) have announced the completion of a...
AbbVie Raises 2025 Outlook as Skyrizi and Rinvoq Surge
NORTH CHICAGO, Ill., November 2, 2025 — AbbVie Inc. (NYSE: ABBV), a global biopharmaceutical leader, has raised its annual...
Advertisement
